Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions-Reference-Cited by-同舟云学术

Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions

Published:2017-09-06 Issue:7 Volume:18 Page:
ISSN:1389-2002
Container-title:Current Drug Metabolism
language:en
Short-container-title:CDM

Author:

Antonijevic Nebojsa M.¹,Zivkovic Ivana D.¹,Jovanovic Ljubica M.¹,Matic Dragan M.¹,Kocica Mladen J.²,Mrdovic Igor B.¹,Kanjuh Vladimir I.³,Culafic Milica D.⁴

Affiliation:

1. Clinic of Cardiology, Clinical Center of Serbia, Belgrade, Serbia

2. Clinic of Cardiosurgery, Clinical Centre of Serbia, Serbia

3. Board of Cardiovascular Pathology, Serbian Academy of Sciences and Arts, Serbia

4. Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08

2. Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation;Journal of Clinical Medicine;2024-04-26

3. Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants;Therapeutic Advances in Cardiovascular Disease;2024-01

4. The key roles of thrombin and fibrinogen in human infant and mice atopic dermatitis models;Allergy;2023-08-30

5. DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives;Journal of Clinical Medicine;2023-07-28